How Ph.D. was paid
$8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Vipin K. Garg, Ph.D.Chief Executive Officer | $658,694 | $1,000 | $1,153,600 | $4,812,167 | $357,753 | $1,043,376 | $8,026,590 |
| Christophe Arbet-Engels, M.D., Ph.D.Chief Medical Officer | $128,750 | $176,000 | $580,500 | $1,388,039 | $50,856 | $5,750 | $2,329,895 |
| M. Scot Roberts, Ph.D.Chief Scientific Officer | $487,306 | $1,000 | $443,800 | $1,055,967 | $192,486 | $2,437 | $2,182,996 |
| M. Scott Harris, M.D.former Chief Medical Officer | $388,403 | $1,000 | $443,800 | $1,373,740 | $204,559 | $219,569 | $2,631,071 |
What changed and why
- $8MVipin K. Garg earned total compensation of $8,026,590 in fiscal 2025 compared to $6,090,462 in fiscal 2024.Dr. Garg stepped down as Chief Executive Officer effective December 31, 2025, and was succeeded by Mr. Durso.Dr. Arbet-Engels joined as Chief Medical Officer in October 2025 with an initial base salary of $515,000.Dr. Harris retired from his position as Chief Medical Officer in September 2025.Dr. Garg's All Other Compensation included $1,007,702 in severance and salary continuation expenses.
Other Altimmune proxy statements
- 2025 proxy statement
Vipin K. Garg, Ph.D. paid $6.1M (+11% on the year).
Filed Aug 15, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.